Loading...
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
Psoriasis vulgaris is a chronic, immune-mediated systemic disease that affectŝ7.5 million people in the US. It can be treated with many therapies, often in combination, which include topicals, phototherapy, oral systemics, and biologics. Biologic agents target specific components of the immune syste...
Na minha lista:
| Udgivet i: | Psoriasis (Auckl) |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774608/ https://ncbi.nlm.nih.gov/pubmed/29387609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PTT.S129792 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|